arrow
M

Matteo Fassan

University of Padua
H指数:90
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating Natural Killer Cells in Patients With Type 2 Diabetes and Peripheral Neuropathy Are Altered in Their Frequency and Exhibit Impaired Functions and Angiogenic Activities

2型糖尿病合并周围神经病变患者外周血自然杀伤细胞频率改变,并表现出功能受损及血管生成活性降低

2026-10-280
OAAI
Comprehensive Clinicopathologic, Immunohistochemical, and Genomic Profiling of Sporadic Ampullary Somatostatin-producing D-cell Neuroendocrine Tumors Identifies Recurrent HRAS Hotspot Mutations

对散发型壶腹素分泌D细胞神经内分泌肿瘤的全面临床病理学、免疫组织化学和基因组特征分析,识别出复发性HRAS热点突变

2026-09-120
OAAI
Universal Tumor Screening in Colorectal Cancer: Role of MMR Immunohistochemistry for Lynch Syndrome and Early-Onset CRC

结直肠癌中的泛肿瘤筛查:MMR免疫组化在林奇综合征和早发型CRC中的作用

Cancers
IF4.4
2026-08-180
OAAI
Double immunohistochemistry to detect transglutaminase 2-IgA deposits in celiac children: a multicentre study

双免疫组化检测乳糜泻儿童中转谷氨酰胺酶2-IgA沉积:一项多中心研究

2026-07-070
OAAI
Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape

胰腺神经内分泌肿瘤的多组学图谱:综合分析

2026-05-290
OA
Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort

揭示腺鳞状胆囊癌的分子特征:对白人队列的表征

2026-05-290
OAAI
Pattern-based histologic approach in colitis with chronic architectural damage: GIPAD recommendations

基于模式的慢性结构损伤性结肠炎的病理学方法:GIPAD建议

2026-05-110
OAAI
Pattern-based histologic approach in colitis without chronic architectural damage: GIPAD recommendations

基于模式的炎症性肠病组织学评估方法(无慢性结构损伤):GIPAD建议

2026-05-020
OAAI
Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations

POLE突变晚期子宫内膜癌的临床和分子异质性:聚焦于侵袭性亚组和共突变

2026-04-290
OA
Adequacy criteria and reporting for prognostic and predictive profiling of biopsies from gastrointestinal neoplasia: A position paper from the Italian group of gastrointestinal pathologists, section of Italian society of anatomic pathology and cytology (GIPAD-SIAPeC-IAP)

活检样本在胃肠道肿瘤预后和预测性分析中的充分性标准与报告要求:意大利胃肠病理学家小组、意大利解剖病理学与细胞学学会分会(GIPAD-SIAPeC-IAP)立场文件

2026-04-011
OAAI
Interlesional genomic heterogeneity in small bowel adenocarcinoma: evidence from matched primary and peritoneal metastatic lesions

小肠腺癌中的病灶内基因组异质性:来自匹配的原发灶和腹膜转移灶的证据

2026-03-250
PRE
Number/quality of endoscopic biopsy samples in gastrointestinal cancers for biomarker testing: All that glitters is not gold

消化道癌症中用于生物标志物检测的内镜活检样本数量/质量:并非所有闪光的东西都是金子

2025-12-260
OAAI
High fidelity of Claudin-18.2 expression in primary and matched metastatic (lymph nodes, peritoneum, and liver) pancreatic ductal adenocarcinoma: a foundation for targeted therapy

Claudin-18.2在原发灶和匹配的转移灶(淋巴结、腹膜和肝脏)胰腺导管腺癌中表达的高保真性:靶向治疗的基础

2025-12-110
OAAI
Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies

肿瘤学中的液体活检:意大利科学学会AIOM-SIAPEC/IAP-SIBioC-SIF赞助的德尔菲共识研究的结果

2025-12-010
PRE